Comprehensive Analysis of the Taxable Year within the Maryland Research and Development Tax Credit Framework

In the context of the Maryland Research and Development tax credit, the taxable year represents the annual accounting period—whether a calendar year, fiscal year, or a short period of less than twelve months—during which a business entity calculates its Maryland taxable income and incurs qualified research expenditures. This designation serves as the temporal anchor for determining the four-year historical base amount, assessing small business asset thresholds, and establishing the specific deadlines for Department of Commerce certification and the subsequent filing of amended tax returns.

Statutory Definitions and the Construction of the Taxable Year

The foundational meaning of a taxable year in Maryland is governed by the Tax-General Article, which seeks to maintain a high degree of conformity with federal tax principles while providing specific carve-outs for state-level administration. According to Maryland Tax-General Code § 10-101(o), a taxable year is defined primarily as the period for which Maryland taxable income is computed under the state’s income tax titles.1 This definition is not limited to a standard twelve-month cycle but includes several distinct structures designed to accommodate the varied operational realities of modern business entities.

Specifically, the law recognizes a calendar year ending on December 31 as defined under Section 441 of the Internal Revenue Code (IRC), as well as a fiscal year ending on the last day of any month other than December.1 Furthermore, the statute explicitly includes periods of less than one year, commonly referred to as short taxable years, which occur when a taxpayer initiates operations, ceases business, or undergoes a permitted change in their accounting period.1 If an election is made under IRC § 441(f) to use a 52-53 week year, Maryland law conforms to that period for the purpose of state filings.1

For the purposes of the Research and Development (R&D) Tax Credit established under § 10-721, the taxable year is the period in which the “Maryland qualified research and development expenses” are “paid or incurred”.3 This alignment with federal timing rules is critical because Maryland adopts the federal definition of qualified research as found in IRC § 41(d) and qualified research expenses as defined in IRC § 41(b).3 Consequently, the taxable year for state R&D purposes is inextricably linked to the taxpayer’s federal reporting period, ensuring that expenses are not shifted between periods to manipulate the credit’s growth-based calculation.

Classification of Taxable Year Structures in Maryland

1

The Regulatory Framework for Short and Partial Taxable Years

While a standard twelve-month period is the norm, the Maryland Department of Commerce and the Comptroller provide extensive guidance on how the R&D credit applies to short or partial taxable years. This is particularly relevant for the “Maryland Adjusted Base Amount,” which must be normalized to prevent a short period of expenses from being unfairly compared against a full year of historical data.

According to Maryland R&D Tax Credit Regulation.03, a partial or short-year taxpayer must calculate an “adjusted base amount” by multiplying the standard Maryland base amount by a fraction.6 The numerator of this fraction is the number of days in the calendar year included in the partial or short tax year, and the denominator is 365.5 This normalization ensures that the threshold for the growth credit remains proportionate to the length of the operating period.

Furthermore, Regulation.11 provides specific instructions for expenses incurred during short years. A taxpayer is restricted to claiming the credit only for expenses actually incurred during the specific dates of that short taxable year.6 If a business entity undergoes a change that results in two taxable years ending within a single calendar year—one of which is a short year—the credit claimable on the short-year return is limited to the total credits certified for the whole calendar year multiplied by a ratio of expenses incurred in the short year to total expenses for the calendar year.6

Normalization Logic for Short Tax Periods

The rationale behind these adjustments is to maintain the integrity of the “growth” component of the credit. Since the Maryland R&D credit is currently a 10% credit on expenses that exceed the base amount, a company that operates for only 181 days (approximately six months) would naturally have lower expenses than a full-year period.5 Without the “adjusted base amount” (which would also be reduced by approximately 50%), the company might never exceed its historical four-year average, effectively disqualifying it from the growth incentive simply because of its shorter operational window.5

The Three-Year Cycle: Application, Certification, and Claiming

One of the most distinctive features of the Maryland R&D tax credit is its administrative timeline, which separates the taxable year in which research is conducted from the year in which the credit is actually applied to a tax return. This cycle is necessitated by the state’s $12 million annual cap and the requirement for the Department of Commerce to prorate credits if oversubscribed.5

Phase 1: The Incurrence Year (Taxable Year 1)

The business conducts qualified research and development in Maryland and incurs the expenses. The entity identifies its taxable year—whether it is a calendar year ending December 31, 2024, or a fiscal year ending June 30, 2024.10 During this period, the entity must ensure that its activities meet the four-part test under IRC § 41 and are physically located in Maryland.8

Phase 2: The Application Year (Year 2)

By November 15 of the calendar year following the end of the taxable year in which the expenses were incurred, the business must submit an online application for certification to the Department of Commerce.3 For a calendar year 2024 taxpayer, this deadline is November 15, 2025.5 For a fiscal year taxpayer whose year ended in 2024, the deadline remains the same.10

Phase 3: The Certification and Claim Year (Year 3)

By February 15 of the calendar year following the application, the Department of Commerce issues a tax credit certificate stating the approved amount.12 Once this certification is received, the taxpayer must file an amended income tax return for the original taxable year in which the expenses were incurred (Taxable Year 1).3 This requirement to amend a prior year’s return is a mandatory procedural step to reconcile the approved credit with the entity’s income tax liability.3

The Standard Administrative Timeline

3

Calculating the Maryland Base Amount Across Taxable Years

The “Maryland Base Amount” is the pivotal threshold that separates non-qualified spending from growth-based spending eligible for the 10% credit. Under § 10-721(a)(3), the base amount is determined using the four taxable years immediately preceding the taxable year in which the research expenses are incurred.3

The Fixed-Base Percentage Mechanism

The first step in the calculation is determining the Maryland fixed-base percentage. This is the ratio of the aggregate Maryland qualified research and development expenses for the four preceding taxable years to the aggregate Maryland gross receipts for those same years.3 If the taxpayer has fewer than four but at least one prior taxable year, the percentage is determined using the available years.4 For a first-year entity or one that has never incurred R&D expenses in Maryland before, the base amount is considered to be zero, allowing the 10% credit to apply to all first-year research spending.7

Average Maryland Gross Receipts

The fixed-base percentage is then multiplied by the average annual Maryland gross receipts for the four taxable years preceding the credit year.5 The resulting figure is the Maryland Base Amount. The growth credit is then 10% of the amount by which the current taxable year’s QREs exceed this base amount.5

Interaction with Acquisitions and Mergers

The concept of the taxable year becomes particularly complex during corporate restructuring. If Company A buys Company B, it is allowed to count Company B’s Maryland qualified R&D expenses for the current taxable year.5 However, the law requires that Company A also include Company B’s historical R&D expenses and gross receipts from previous taxable years when calculating the four-year base amount.5 This prevents companies from artificially inflating their “growth” by simply acquiring existing research operations.

Small Business Qualification and the Net Book Value Asset Test

Maryland law provides a significant benefit to “Small Businesses” by making their R&D tax credits fully refundable if they exceed the entity’s tax liability for the taxable year.3 The determination of whether a business is “small” is tied directly to its financial standing during the taxable year for which the credit is claimed.

The $5 Million Threshold

A small business is defined as a for-profit corporation, LLC, partnership, or sole proprietorship with “net book value assets” totaling less than $5 million.3 Crucially, this asset test must be satisfied at either the beginning or the end of the taxable year for which the R&D expenses were incurred.3

Net Book Value Asset Definition

Official guidance defines “net book value assets” as the total value of all assets, including intangibles, as reported on the balance sheet, minus depreciation and amortization.8 Importantly, liabilities are not deducted from this figure; it is a measure of gross asset value net of accumulated depreciation.8 This measurement ensures that capital-intensive businesses with high leverage do not qualify as small businesses if they control significant asset bases.

Refundability Mechanism

For a certified small business, if the approved credit (after proration) exceeds the State income tax for the taxable year, the business may claim a refund of the excess.3 This is often the primary reason why small tech and biotech firms apply for the credit, as it provides a direct infusion of cash during years when they may still be pre-revenue or in a loss position.8

3

Annual Statutory Caps and Proration Across Applications

The Maryland R&D tax credit is not an open-ended entitlement. It is subject to a hard cap of $12 million per calendar year for all certified credits.3 To ensure a fair distribution of these limited resources, the Department of Commerce manages the funds across two distinct pools based on the status of the applicants.

The Two-Tiered Funding Structure

1. Non-Small Business Pool: $8.5 million is allocated to businesses that do not meet the small business asset test.3
2. Small Business Pool: $3.5 million is set aside specifically for qualified small businesses.3

If the total credits applied for in either pool exceed the allocated amount, the Department must prorate the awards.5 For example, if large corporations apply for $17 million in growth credits, but only $8.5 million is available, each corporation would receive only 50% of the credit for which it otherwise qualified.5

Reallocation and the $250,000 Individual Limit

The law allows for the reallocation of funds between pools if one is under-applied. If small businesses only apply for $2.5 million, the remaining $1 million is shifted to the non-small business pool to mitigate the effects of proration for larger firms.4 Furthermore, no single entity can receive more than $250,000 in credits for a single taxable year, regardless of the size of their R&D spend.5 This per-firm cap was introduced to ensure that a handful of major aerospace or pharmaceutical companies do not exhaust the entire $12 million fund.

State Revenue Office Guidance and Procedural Compliance

The Comptroller of Maryland provides administrative releases and specific instructions to ensure that the R&D credit is correctly reported on state income tax returns. These procedures are vital, as even a certified credit can be denied if the filing requirements for the taxable year are not met.

Form 500CR and Electronic Filing

The R&D credit must be reported on Maryland Form 500CR (Business Income Tax Credits).11 Under current state directives, if a corporation or pass-through entity (PTE) intends to claim the R&D tax credit, it must file its return electronically.11 The Comptroller may grant a waiver for this requirement (using Form 500CRW) only if the taxpayer can demonstrate reasonable cause or undue hardship.11

The Role of Pass-Through Entities (PTEs)

For entities like S corporations, partnerships, and LLCs, the credit is generated at the entity level but used by the members on their individual returns.8 According to Regulation.13, the credits are claimed on the member’s Maryland return in the taxable year during which the taxable year of the PTE ends.6 If a PTE has a fiscal year ending January 31, 2024, the calendar-year individual member would report that credit on their 2024 tax return (the year in which the PTE’s fiscal year concluded).

Substantiation and Record Retention

To survive an audit, the Comptroller and Department of Commerce advise taxpayers to maintain records for at least four years following the taxable year in which the credit was claimed.8 These records should include project descriptions, payroll logs for employees engaged in research, invoices for supplies, and detailed gross receipt reports for the four-year base period.8

Key Comptroller Filing Instructions

11

Comprehensive Example: The “AeroTech Solutions” Growth Cycle

To illustrate the interplay of the taxable year, base amount, and certification timeline, we examine the case of AeroTech Solutions, a Maryland-based manufacturing firm specializing in drone technology.

Step 1: Establishing the Credit Year (2024)

AeroTech Solutions operates on a calendar taxable year. In 2024, the company spends $1,000,000 on Maryland qualified research expenses (QREs). To calculate its eligibility, it looks at the four preceding taxable years (2020, 2021, 2022, and 2023).

• Average Maryland Gross Receipts (2020-2023): $5,000,000.
• Average Maryland QREs (2020-2023): $600,000.
• Fixed-Base Percentage: $600,000 / $5,000,000 = 12%.
• Maryland Base Amount: 12% of $5,000,000 = $600,000.
• Eligible Excess: $1,000,000 (Current) – $600,000 (Base) = $400,000.
• Potential Growth Credit: 10% of $400,000 = $40,000.

Step 2: The Asset Test and Small Business Status

On January 1, 2024, AeroTech’s balance sheet showed net book value assets (Gross assets minus depreciation) of $4,200,000. Even though the company grew and reached $6,000,000 in assets by December 31, 2024, it qualifies as a “Small Business” because it was under the $5 million threshold at the beginning of the taxable year.3

Step 3: Application and Proration (2025)

AeroTech submits its application by November 15, 2025. During the review process, the Department of Commerce determines that small businesses applied for a total of $7 million in credits. Since only $3.5 million is available, a 50% proration is applied to all small business applicants.5

Step 4: Certification and Refund (2026)

In February 2026, AeroTech receives certification for a $20,000 credit (50% of the $40,000 originally calculated). The company then files an amended 2024 Maryland income tax return. If AeroTech’s state tax liability for 2024 was only $5,000, the company would receive a check from the Comptroller for $15,000—the refundable portion of the credit.3

Federal Conformity and the Impact of IRC Section 174 Capitalization

A significant shift in the value proposition of the R&D credit occurred for taxable years beginning after December 31, 2021, due to changes in the federal Tax Cuts and Jobs Act (TCJA).25 Historically, businesses could immediately deduct 100% of their R&D expenses. Under the new IRC Section 174 rules, these expenses must now be capitalized and amortized over five years for domestic research.25

The Maryland Manufacturing Advisory Board (MMAB) has highlighted that this change effectively increases the taxable income of research-intensive firms in the short term, as they lose the full immediate deduction.26 While Maryland’s R&D tax credit is still calculated based on 10% of growth expenses, the state follows federal income calculations for its tax base.11 Consequently, many businesses find that their state income tax liability has increased, making the R&D credit more necessary but also potentially less impactful relative to the increased tax burden from capitalization.26

Carryforward Limitations and Long-Term Utilization

For businesses that do not qualify for the small business refund (those with over $5 million in net book value assets), the R&D credit is non-refundable. If the credit exceeds the state income tax liability for the taxable year in which the expenses were incurred, the unused portion may be carried forward to subsequent taxable years.3

The 7-Year Expiry Rule

The current statutory text specifies that any unused credit may be carried forward for up to 7 taxable years after the taxable year in which the Maryland qualified research and development expense was incurred.3 This is a critical distinction from federal R&D credits, which often have longer carryforward periods (up to 20 years).25 Maryland businesses must carefully monitor their 7-year window to ensure the credits do not expire unused.

Transfers and Mergers

While Maryland has historically been restrictive regarding the transfer of tax credits, recent legislative proposals (such as the 2025 DECADE Act and SB 35) aim to allow technology companies with unused R&D credits to transfer them to other taxpayers.16 This would represent a fundamental change in how the credit interacts with the taxable year, potentially allowing companies to monetize their research investment more quickly than the standard carryforward allows.

Statistical Trends and Economic Evaluation of the Program

The 2024 evaluation of the Research and Development Tax Credit by the Department of Legislative Services (DLS) provides a clear picture of the program’s reach and limitations. While the program is viewed as a successful “branding” tool for Maryland as a pro-innovation state, its fiscal impact is tightly controlled by the $12 million cap.28

Applicant Distribution and Proration Data

The DLS report indicates that the elimination of the “Basic” credit in 2021 has significantly helped mitigate oversubscription for small businesses.17 By directing funds away from established firms that were not increasing their research spend and toward growth-oriented firms, the proration percentages for small businesses have historically been more favorable than for the general pool.17

Program Effectiveness Findings

The DLS concludes that the redesigned program is unlikely to meaningfully impact total statewide R&D activity due to the relatively small size of the awards compared to total private-sector R&D investment in Maryland.28 However, for specific industries like biotechnology, the credit remains a critical source of non-dilutive capital, especially for firms in the “pre-revenue” phase where the $250,000 refund can fund several months of payroll or laboratory supplies.8

Future Outlook: Sunset and Reauthorization

The Maryland R&D tax credit program is currently set to expire for taxable years beginning on or after January 1, 2026.5 The overall program authority terminates on June 30, 2027, unless the Maryland General Assembly acts to extend it.5 Given the program’s popularity with the state’s burgeoning tech and life sciences corridors, extension is a regular feature of legislative sessions, but taxpayers must remain vigilant about these dates for long-term financial planning.

The Governor’s 2025 legislative agenda, including the DECADE Act, suggests a continued focus on streamlining these credits and potentially increasing the caps to help Maryland remain competitive with neighboring states like Virginia and Pennsylvania, which have their own robust R&D incentive programs.27

Final Synthesis and Strategic Recommendations

The “taxable year” is not merely an accounting period in the context of the Maryland R&D tax credit; it is a complex legal construction that determines the validity of every research dollar spent. Businesses must view the credit as a multi-year project requiring precise coordination between R&D teams, accounting departments, and state agencies.

To maximize the benefit of this incentive, firms should consider the following:

• Asset Management: Companies near the $5 million threshold should meticulously calculate their net book value at both the start and end of their taxable year to ensure they do not inadvertently lose refundability by missing a $4.99 million snapshot.3
• Documentation Continuity: Because the base amount calculation relies on a four-year lookback, losing records from four years ago can disqualify a claim for the current taxable year.5
• Strategic Growth Timing: Since the credit is growth-based, companies planning significant R&D expansions should ensure those expenses fall within a single taxable year to maximize the 10% delta above the four-year average.3
• Compliance Awareness: The shift to mandatory electronic filing and the requirement to file amended returns for the original incurrence year are the most common points of failure for taxpayers claiming the credit.3

Through a comprehensive understanding of the Maryland Tax-General Code and local Revenue Office guidance, business entities can turn the administrative challenge of the R&D credit into a reliable financial tool for fostering innovation within the state.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/